SITC 2026 has ended. This guide stays up as the record of who was there. Next: SITC 2027, Nov 3–7, 2027 in National Harbor
Novartis at SITC 2026
Nov 4–8, 2026 Phoenix, AZ ~6k attendees Website
Novartis brings 3 presentations to SITC 2026 in Phoenix. Its program centres on combining immunotherapy with radiation and radiopharmaceuticals, and on working with patient advocates and writing for lay readers. A concrete study maps which tumor antigens T cells respond to in kidney cancer patients treated with checkpoint blockade.
| Organization | SITC 2026 Attendance |
|---|---|
Novartis Basel, Switzerland | |
Swiss pharmaceutical company whose oncology medicines include radioligand therapies and CAR T-cell therapy. | Session Thu Nov 5 4:05pm–4:30pm Talk Thu Nov 5 4:30pm–5:00pm Poster Fri Nov 6 12:15–1:45pm 5:30–7pm Poster Sat Nov 7 12–1:30pm 6:40–8:10pm Session Sat Nov 7 3:30pm–4:50pm Novel Paradigms for Effectively Combining Immunotherapies with Radiopharmaceuticals or Radiation Therapy
|
Find decision makers at Novartis
Tell us what you sell and we’ll find the people at Novartis most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the Society for Immunotherapy of Cancer (SITC). Submit a correction